Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News What’s going on at Olema Oncology? CFO + COO Hans Bishop exits suddenly Olema Oncology CFO and COO Hans Bishop has stepped down ahead of OP-1250 trial milestones. Find out what this means for investors and pipeline strategy. byPallavi MadhirajuJanuary 31, 2026